Anran Li - Angel Investor Profile

Anran Li, a partner at Octagon Capital, joined Epicrispr Biotechnologies’ board after leading the $90 million Series C financing. He focuses on biotech and healthcare investments, supporting breakthrough epigenetic therapies.

Investment Focus & Industries

  • health
  • deeptech
AL

Anran Li

Verified: Aug 2026 (SMTP Validated)👑 Lead Investor
𝕏 Twitter/Xin LinkedIn
Check Size Range

Flexible Check Size

Preferred Stages
Pre-seed & Seed

Background & Investment Thesis

Anran Li, a partner at Octagon Capital, joined Epicrispr Biotechnologies’ board after leading the $90 million Series C financing. He focuses on biotech and healthcare investments, supporting breakthrough epigenetic therapies.

Focus Industries

healthdeeptech
AI Outreach Insight94% Match Score

Active investor in health, deeptech. Highly responsive to concise pitches with clear traction metrics.

Anran Li - Angel Investor Profile | OpenAngels